Key result
Chemically modified G-quadruplex-forming aptamers targeting cellular prion protein demonstrate enhanced anti-prion properties.
Why the study?
Nucleic acid aptamers are promising candidates to block prion protein conversion, but they need chemical modifications for effective therapeutic activity.
Chemical modifications of G-quadruplex-forming aptamers can enhance their anti-prion activity, offering potential therapeutic candidates for prion diseases.
Answers are grounded in this paper and cite their sources.
May inform aptamer optimization for prion diseases; leaves open human translation from animal data.
Nucleic acid aptamers are innovative and promising candidates to block the hallmark event in the prion diseases, that is the conversion of prion protein (PrP) into an abnormal form; however, they need chemical modifications for effective therapeutic activity. This communication reports on the development and biophysical characterization of a small library of chemically modified G-quadruplex-forming aptamers targeting the cellular PrP and the evaluation of their anti-prion activity. The results show the possibility of enhancing anti-prion aptamer properties through straightforward modifications.
No takes yet. Share an insight, caveat, or question.
Amato et al. (2020) studied Prion diseases. Chemically modified G-quadruplex-forming aptamers was evaluated on Anti-prion activity and biophysical characterization. Chemically modified G-quadruplex-forming aptamers targeting cellular prion protein demonstrated enhanced anti-prion properties through straightforward chemical modifications.
Synapse has enriched 10 related papers. Consider them for comparative context: